Ekso Bionics Holdings Interest Expense 2011-2026 | EKSO

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Ekso Bionics Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-26 K	-1 K	-63 K	156 K	113 K	139 K	384 K	600 K	648 K	16 K	13 K	435 K	1.73 M	736 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.73 M	-63 K	348 K

Quarterly Interest Expense Ekso Bionics Holdings

2026-Q1	2025-Q4	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-13 K	-	-8 K	-6 K	-	-2 K	-	57 K	-	3 K	-30 K	112 K	-	34 K	29 K	27 K	-	24 K	27 K	26 K	-	23 K	38 K	52 K	-	88 K	107 K	121 K	-	145 K	160 K	163 K	-	165 K	198 K	119 K	-	-1.61 M	1.63 M	2.99 M	-	4 K	3 K	3 K	-	3 K	3 K	427 K	-	170 K	674 K	639 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.99 M	-1.61 M	174 K

Interest Expense of other stocks in the Medical instruments industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
The Cooper Companies COO	-16.4 M	$ 60.84	0.76 %	$ 12.1 B	USA
Atrion Corporation ATRI	149	-	-	$ 810 M	USA
ICU Medical ICUI	93.3 M	$ 122.4	-0.48 %	$ 3.02 B	USA
iRhythm Technologies IRTC	5.44 M	$ 114.08	-0.07 %	$ 3.65 B	USA
Alcon ALC	204 M	$ 64.65	1.02 %	$ 40.4 B	Schweiz
Repro Med Systems KRMD	9.91 K	$ 3.91	-1.75 %	$ 181 M	USA
LeMaitre Vascular LMAT	5.18 M	$ 99.4	-0.1 %	$ 2.25 B	USA
Masimo Corporation MASI	300 K	$ 178.41	0.03 %	$ 9.51 B	USA
Envista Holdings Corporation NVST	-2.3 M	$ 23.9	0.21 %	$ 4.02 B	USA
electroCore ECOR	14.9 K	$ 6.3	-2.02 %	$ 53.4 K	USA
Haemonetics Corporation HAE	-9.75 M	$ 57.35	0.46 %	$ 2.89 B	USA
Isoray ISR	84 K	-	0.03 %	$ 108 M	USA
Glaukos Corporation GKOS	13.6 M	$ 143.0	0.6 %	$ 6.93 B	USA
STAAR Surgical Company STAA	2.25 M	$ 31.91	-0.31 %	$ 1.58 B	USA
STERIS plc STE	8.4 M	$ 216.15	0.08 %	$ 21.3 B	USA
Teleflex Incorporated TFX	85.1 M	$ 130.56	0.21 %	$ 5.83 B	USA
InfuSystem Holdings INFU	2 K	$ 8.43	-2.37 %	$ 174 M	USA
Microbot Medical MBOT	-5 K	$ 1.92	3.69 %	$ 87.9 M	Israel
Milestone Scientific MLSS	60.3 K	$ 0.34	-1.02 %	$ 27.9 M	USA
Merit Medical Systems MMSI	-2.39 M	$ 62.37	-0.3 %	$ 3.69 B	USA
Utah Medical Products UTMD	-120 K	$ 63.24	-0.72 %	$ 205 M	USA
West Pharmaceutical Services WST	-1 M	$ 301.21	0.34 %	$ 21.8 B	USA
Pulse Biosciences PLSE	-52 K	$ 25.45	-6.09 %	$ 1.72 B	USA
DENTSPLY SIRONA XRAY	24 M	$ 10.1	-3.03 %	$ 2.01 B	USA
Retractable Technologies RVP	227 K	$ 0.69	-0.01 %	$ 20.7 M	USA
Pro-Dex PDEX	533 K	$ 57.73	-1.57 %	$ 190 M	USA
Predictive Oncology POAI	3	-	-	$ 31.1 M	USA
BioLife Solutions BLFS	1.82 M	$ 20.76	-1.42 %	$ 991 M	USA
Stereotaxis STXS	2 K	$ 1.89	-2.83 %	$ 172 M	USA
Baxter International BAX	290 M	$ 17.62	-0.96 %	$ 9.04 B	USA
ResMed RMD	3.2 M	$ 204.91	1.21 %	$ 29.9 B	USA
AtriCure ATRC	683 K	$ 28.69	1.92 %	$ 1.37 B	USA
Harvard Bioscience HBIO	-2.66 M	$ 5.34	-3.26 %	$ 237 M	USA
AngioDynamics ANGO	4.94 M	$ 10.98	-0.45 %	$ 449 M	USA
Becton, Dickinson and Company BDX	613 M	$ 143.99	-0.33 %	$ 41.4 B	USA
Nephros NEPH	-78 K	$ 3.2	-4.23 %	$ 34 M	USA
OraSure Technologies OSUR	229 K	$ 3.04	3.05 %	$ 223 M	USA
Repligen Corporation RGEN	2.82 M	$ 106.8	3.31 %	$ 6.01 M	USA